These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 20434010)

  • 1. Heparanase procoagulant effects and inhibition by heparins.
    Nadir Y; Brenner B
    Thromb Res; 2010 Apr; 125 Suppl 2():S72-6. PubMed ID: 20434010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparanase coagulation and cancer progression.
    Nadir Y; Brenner B
    Best Pract Res Clin Haematol; 2009 Mar; 22(1):85-92. PubMed ID: 19285275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparanase, tissue factor, and cancer.
    Nadir Y; Vlodavsky I; Brenner B
    Semin Thromb Hemost; 2008 Mar; 34(2):187-94. PubMed ID: 18645924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells.
    Nadir Y; Brenner B; Gingis-Velitski S; Levy-Adam F; Ilan N; Zcharia E; Nadir E; Vlodavsky I
    Thromb Haemost; 2008 Jan; 99(1):133-41. PubMed ID: 18217145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparanase, heparin and the coagulation system in cancer progression.
    Vlodavsky I; Ilan N; Nadir Y; Brenner B; Katz BZ; Naggi A; Torri G; Casu B; Sasisekharan R
    Thromb Res; 2007; 120 Suppl 2():S112-20. PubMed ID: 18023704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparanase procoagulant activity.
    Nadir Y; Brenner B
    Thromb Res; 2012 Apr; 129 Suppl 1():S76-9. PubMed ID: 22682139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparanase multiple effects in cancer.
    Nadir Y; Brenner B
    Thromb Res; 2014 May; 133 Suppl 2():S90-4. PubMed ID: 24862152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparanase procoagulant activity in cancer progression.
    Nadir Y; Brenner B
    Thromb Res; 2016 Apr; 140 Suppl 1():S44-8. PubMed ID: 27067977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparanase modulates heparinoids anticoagulant activities via non-enzymatic mechanisms.
    Katz BZ; Muhl L; Zwang E; Ilan N; Herishanu Y; Deutsch V; Naparstek E; Vlodavsky I; Preissner KT
    Thromb Haemost; 2007 Dec; 98(6):1193-9. PubMed ID: 18064313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of tissue factor pathway inhibitor in tumor growth and metastasis.
    Amirkhosravi A; Meyer T; Amaya M; Davila M; Mousa SA; Robson T; Francis JL
    Semin Thromb Hemost; 2007 Oct; 33(7):643-52. PubMed ID: 18000790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An assay to evaluate heparanase procoagulant activity.
    Nadir Y; Kenig Y; Drugan A; Shafat I; Brenner B
    Thromb Res; 2011 Oct; 128(4):e3-8. PubMed ID: 21481923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of unfractionated heparin and a low molecular weight heparin (enoxaparin) on coagulant activity of cultured human endothelial cells.
    Martinez-Sales V; Vila V; Réganon E; Oms JG; Aznar J
    Haematologica; 2003 Jun; 88(6):694-9. PubMed ID: 12801846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation.
    Zetser A; Bashenko Y; Edovitsky E; Levy-Adam F; Vlodavsky I; Ilan N
    Cancer Res; 2006 Feb; 66(3):1455-63. PubMed ID: 16452201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis.
    Ilan N; Elkin M; Vlodavsky I
    Int J Biochem Cell Biol; 2006; 38(12):2018-39. PubMed ID: 16901744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of heparanase in vaginal and cesarean section deliveries.
    Nadir Y; Kenig Y; Drugan A; Zcharia E; Brenner B
    Thromb Res; 2010 Dec; 126(6):e444-50. PubMed ID: 20932554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural requirements for inhibition of melanoma lung colonization by heparanase inhibiting species of heparin.
    Bitan M; Mohsen M; Levi E; Wygoda MR; Miao HQ; Lider O; Svahn CM; Ekre HP; Ishai-Michaeli R; Bar-Shavit R
    Isr J Med Sci; 1995; 31(2-3):106-18. PubMed ID: 7744578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer.
    Joyce JA; Freeman C; Meyer-Morse N; Parish CR; Hanahan D
    Oncogene; 2005 Jun; 24(25):4037-51. PubMed ID: 15806157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel peptides that inhibit heparanase activation of the coagulation system.
    Axelman E; Henig I; Crispel Y; Attias J; Li JP; Brenner B; Vlodavsky I; Nadir Y
    Thromb Haemost; 2014 Sep; 112(3):466-77. PubMed ID: 25030319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparanase in the Coagulation System.
    Nadir Y
    Adv Exp Med Biol; 2020; 1221():771-784. PubMed ID: 32274737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexpression of heparanase activity, cathepsin L, tissue factor, tissue factor pathway inhibitor, and MMP-9 in proliferative diabetic retinopathy.
    Abu El-Asrar AM; Siddiquei MM; Nawaz MI; De Hertogh G; Mohammad G; Alam K; Mousa A; Opdenakker G
    Mol Vis; 2016; 22():424-35. PubMed ID: 27168718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.